Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Statistics

Sense and nonsense of studies (not only) in pain medicine

    • Congress Reports
    • General Internal Medicine
    • RX
    • Studies
  • 3 minute read

Michael A. Überall, MD, Nuremberg, Germany, took a closer look at the pitfalls of reading study publications and the significance of statistical data in a series of seminars. In doing so, he recommended trusting in one’s common sense and not being misled by numbers. This is because many studies are deceptive and already offer in the abstract that a closer examination of the contents is not worthwhile.

Every year, countless studies are published on the effectiveness – or ineffectiveness – of therapies. A central criterion in the evaluation of efficacy is the p-value: If statistical significance is missed with a value of >0.05, a study is generally considered to have failed. “The p-value, however, says nothing about right or wrong, but merely indicates a probability,” explained Überall. Thus, a p-value ≤0.05 means that the result is certain with a probability of 95% or more. However, the value can also be reached by chance. With a p-value of 0.06, the result is still 94% certain – and the difference from p≤0.05 minimal. “Does a p-value >0.05 therefore really mean that the therapy is not working? We should question whether this convention is correct,” he said. This is because a p-value =0.06 could mean that a drug that may be urgently needed by many patients does not receive approval.

The certainty that a difference between two groups is not random can be increased by p-values <0.01 or <0.001. A p-value <0.001 is considered highly significant – and the result 99.9% reliable. However, an error probability of 0.1% would mean that 445,000 prescriptions would be filled incorrectly every year or that one of the airplanes taking off or landing in Frankfurt would crash every other day, Überall pointed out. Thus, even a p-value <0.001 does not provide 100% certainty. In his view, one of the most important values in medicine is the confidence interval, which is usually given as 95%. If the range encloses the value 1 or if the confidence intervals of two therapies overlap, the documented differences in efficacy are statistically irrelevant. “Then you can safely put the study aside,” Überall affirmed.

If the study does not deliver what it promises

As far as reading studies in general is concerned, a glance at the abstract is often enough to see whether further reading is worthwhile. Überall illustrated this with the example of a study on the treatment of neuropathic pain in patients with multiple sclerosis. The investigational drug was no more effective than placebo in terms of pain relief – but caused side effects twice as often. Nevertheless, the authors write in the title of the publication that the drug is a safe option for long-term therapy of neuropathic pain. “Therefore, read with common sense whether the content of a publication delivers what the title promises,” Überall appealed to the congress participants.

Wrong conclusions from incorrect evaluations

The extent to which study data can be misleading is shown by an evaluation that played into the hands of skeptics of the Corona vaccine in 2021. For example, according to data from the Bavarian Ministry of Health, vaccinated people had a higher mortality rate of 4.3% than unvaccinated people at 3.4%. Older people, however, were greatly overrepresented in the evaluation – and after weighting for age, it appeared that the vaccinated had a lower risk of death than the unvaccinated. What do we learn from this? Reading studies also needs to be learned.

Source: Everywhere M: Statistics in pain medicine. German Pain and Palliative Day 2023

InFo NEUROLOGY & PSYCHIATRY 2023; 21(2): 29.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • evaluation
  • Study
Previous Article
  • "Healthy living in pregnancy" study

Nutrient supplementation – what to consider?

  • Education
  • General Internal Medicine
  • Gynecology
  • Nutrition
  • RX
  • Studies
View Post
Next Article
  • Plaque psoriasis

Current 5-year data on secukinumab

  • Allergology and clinical immunology
  • Dermatology and venereology
  • Education
  • Rheumatology
  • RX
  • Studies
  • Unkategorisiert
View Post
You May Also Like
View Post
  • 4 min
  • Pathophysiological mechanisms and therapeutic perspectives

Metabolic syndrome in patients with schizophrenia

    • Cardiology
    • Education
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Hand eczema: from diagnosis to treatment

Implementing sustainable, stage-appropriate measures

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Cystic fibrosis

Small spray – big footprint

    • Education
    • General Internal Medicine
    • Pediatrics
    • Pneumology
    • RX
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal pain – Gastric outlet stenosis

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Radiology
    • RX
    • Surgery
View Post
  • 6 min
  • When the bones become more fragile: “Case Finding”

Fracture risk reduction in osteoporosis

    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Biologics for plaque psoriasis

What increases the chance of a sustained remission?

    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 12 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • CME continuing education
    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 16 min
  • Pain and autism

Hurdles to pain treatment for autistic patients

    • CME continuing education
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Hurdles to pain treatment for autistic patients
  • 2
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 3
    Treatment of comorbidities in older people
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Rare malignancy from a dermatological perspective

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.